Home > Insider Trading > Biomarin Pharmaceutical Inc

Biomarin Pharmaceutical Inc (BMRN)

Market is closed

Get Email Alerts

Profile
Hedge Fund Holdings
Insider Purchases
Insider Sales
Institutional Holdings
13 D/G Filings
News

Get Email Alerts

News

First
<< Previous
81 - 90
Next >>

Is BioMarin Pharmaceutical Inc. (BMRN) A Good Stock To Buy?

Between June 25 and October 30th the Russell 2000 ETF (IWM) lagged the larger S&P 500 ETF (SPY) by more than 14 percentage points as investors worried over the possible ramifications of rising interest...

Keep Reading →

November 30th, 2015 - Hedge Funds News

BioMarin Pharmaceutical Inc. (BMRN) Surges But Is It A Good Stock To Buy Now?

Is BioMarin Pharmaceutical Inc.

Keep Reading →

June 18th, 2015 - Hedge Funds News

Endo International plc (ENDP), BioMarin Pharmaceutical Inc. (BMRN): Visium Picks Returned 13% but Net Returns Were Only 5% - Here's Why

The broad portfolio of Jacob Gottlieb’s Visium Asset Management enjoyed a very strong quarter, with the weighted average returns of its 817 reported positions in companies with market-caps of greater...

Keep Reading →

April 10th, 2015 - Hedge Funds News

Billionaire John Griffin's Five Picks That Killed the Market This Quarter

John Griffin’s Blue Ridge Capital had a great start to the year, as its 45 long positions in stocks with a market cap above $1.0 billion returned 6.8% in the first quarter.

Keep Reading →

April 9th, 2015 - Hedge Funds News

Era Group Inc (ERA), BioMarin Pharmaceutical Inc. (BMRN), & Assured Guaranty Ltd. (AGO) Among Stocks Amici Capital Is Bullish on

Paul Orlin's Amici Capital has increased its exposure to Era Group Inc (NYSE:ERA), as a new filing with the Securities and Exchange Commission shows.

Keep Reading →

March 27th, 2015 - Hedge Funds News

Palo Alto Rejoicing at ABIOMED, Inc. (ABMD)'s 18% Spike

ABIOMED, Inc. (NASDAQ:ABMD) spiked as high as 21% in Tuesday's intraday trading to eventually close at 18% in the green at $72.48.

Keep Reading →

March 25th, 2015 - Hedge Funds Market Movers News

BioMarin Pharmaceutical Inc. (BMRN) and Other Top New Picks of Healthcare-Focused Visium Asset Management

Jacob Gottlieb's Visium Asset Management has recently revealed its equity positions as of the end of the fourth quarter in a 13F filing with the Securities and Exchange Commission.

Keep Reading →

March 3rd, 2015 - Hedge Funds News

Tang Capital Management Discloses Moves into La Jolla Pharmaceutical Company (LJPCD), Vanda Pharmaceuticals Inc. (VNDA), Mirati Therapeutics Inc. (MRTX) & Others

Tang Capital Management, led by Kevin C. Tang, revealed in a filing several moves that have impacted its equity portfolio.

Keep Reading →

January 16th, 2014 - Hedge Funds News

Hedge Fund Bets On Onyx Pharmaceuticals, Inc. (ONXX)

As fast as we can type this, Phill Gross and Robert Atchinson's hedge fund, Adage Capital Partners, disclosed ownership of about 3.7 million shares of Onyx Pharmaceuticals, Inc.

Keep Reading →

September 9th, 2013 - News